These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15200949)

  • 21. A family of cyclin-like proteins that interact with the Pho85 cyclin-dependent kinase.
    Measday V; Moore L; Retnakaran R; Lee J; Donoviel M; Neiman AM; Andrews B
    Mol Cell Biol; 1997 Mar; 17(3):1212-23. PubMed ID: 9032248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Swe1 regulation and transcriptional control restrict the activity of mitotic cyclins toward replication proteins in Saccharomyces cerevisiae.
    Hu F; Aparicio OM
    Proc Natl Acad Sci U S A; 2005 Jun; 102(25):8910-5. PubMed ID: 15956196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cks1 is required for G(1) cyclin-cyclin-dependent kinase activity in budding yeast.
    Reynard GJ; Reynolds W; Verma R; Deshaies RJ
    Mol Cell Biol; 2000 Aug; 20(16):5858-64. PubMed ID: 10913169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in E2F complexes containing retinoblastoma protein family members and increased cyclin-dependent kinase inhibitor activities during terminal differentiation of cardiomyocytes.
    Flink IL; Oana S; Maitra N; Bahl JJ; Morkin E
    J Mol Cell Cardiol; 1998 Mar; 30(3):563-78. PubMed ID: 9515032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
    Phelps DE; Xiong Y
    Cell Growth Differ; 1998 Aug; 9(8):595-610. PubMed ID: 9716177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclin-dependent kinases: inhibition and substrate recognition.
    Endicott JA; Noble ME; Tucker JA
    Curr Opin Struct Biol; 1999 Dec; 9(6):738-44. PubMed ID: 10607671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multisite phosphorylation code of CDK.
    Örd M; Möll K; Agerova A; Kivi R; Faustova I; Venta R; Valk E; Loog M
    Nat Struct Mol Biol; 2019 Jul; 26(7):649-658. PubMed ID: 31270471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The phosphatase Cdc14 triggers mitotic exit by reversal of Cdk-dependent phosphorylation.
    Visintin R; Craig K; Hwang ES; Prinz S; Tyers M; Amon A
    Mol Cell; 1998 Dec; 2(6):709-18. PubMed ID: 9885559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Late-G1 cyclin-CDK activity is essential for control of cell morphogenesis in budding yeast.
    Moffat J; Andrews B
    Nat Cell Biol; 2004 Jan; 6(1):59-66. PubMed ID: 14688790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Substrate targeting of the yeast cyclin-dependent kinase Pho85p by the cyclin Pcl10p.
    Wilson WA; Mahrenholz AM; Roach PJ
    Mol Cell Biol; 1999 Oct; 19(10):7020-30. PubMed ID: 10490639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphorylation-dependent binding of mitotic cyclins to Cdc6 contributes to DNA replication control.
    Mimura S; Seki T; Tanaka S; Diffley JF
    Nature; 2004 Oct; 431(7012):1118-23. PubMed ID: 15496876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Highly potent p21(WAF1)-derived peptide inhibitors of CDK-mediated pRb phosphorylation: delineation and structural insight into their interactions with cyclin A.
    Zheleva DI; McInnes C; Gavine AL; Zhelev NZ; Fischer PM; Lane DP
    J Pept Res; 2002 Nov; 60(5):257-70. PubMed ID: 12383116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective degradation of ubiquitinated Sic1 by purified 26S proteasome yields active S phase cyclin-Cdk.
    Verma R; McDonald H; Yates JR; Deshaies RJ
    Mol Cell; 2001 Aug; 8(2):439-48. PubMed ID: 11545745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphorylation and activation of B-Myb by cyclin A-Cdk2.
    Ziebold U; Bartsch O; Marais R; Ferrari S; Klempnauer KH
    Curr Biol; 1997 Apr; 7(4):253-60. PubMed ID: 9094315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors.
    Adams PD; Sellers WR; Sharma SK; Wu AD; Nalin CM; Kaelin WG
    Mol Cell Biol; 1996 Dec; 16(12):6623-33. PubMed ID: 8943316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional analysis of the Ume3p/ Srb11p-RNA polymerase II holoenzyme interaction.
    Cooper KF; Strich R
    Gene Expr; 1999; 8(1):43-57. PubMed ID: 10543730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cyclin family of budding yeast: abundant use of a good idea.
    Andrews B; Measday V
    Trends Genet; 1998 Feb; 14(2):66-72. PubMed ID: 9520600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the interactions between human cdc25C, cdks, cyclins and cdk-cyclin complexes.
    Morris MC; Divita G
    J Mol Biol; 1999 Feb; 286(2):475-87. PubMed ID: 9973565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Degradation of p27(Kip) cdk inhibitor triggered by Kaposi's sarcoma virus cyclin-cdk6 complex.
    Ellis M; Chew YP; Fallis L; Freddersdorf S; Boshoff C; Weiss RA; Lu X; Mittnacht S
    EMBO J; 1999 Feb; 18(3):644-53. PubMed ID: 9927424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclin/Cdk complexes: their involvement in cell cycle progression and mitotic division.
    John PC; Mews M; Moore R
    Protoplasma; 2001; 216(3-4):119-42. PubMed ID: 11732181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.